A New Strategy to Treat Disease
Synlogic is harnessing the power of synthetic biology to design biotherapeutic medicines programmed with specific genes and molecular components to address dysregulation and other drivers of disease. Based on our understanding of the proprietary switches and genetic systems able to activate, inhibit or modulate activity to treat disease, these “Synthetic Biotics” have the potential to treat a range of conditions including rare diseases, metabolic conditions, autoimmune and inflammatory diseases.
Synthetic Biotics are potential biotherapeutics enabled by Synlogic’s proprietary, reproducible, target-specific drug design.
Delivering Our Medicines for Optimal Effect
Synlogic’s biotherapeutic drug candidates, called Synthetic Biotics, are created to act locally while delivering a systemic effect. Our therapy for PKU is administered orally, working through the gut to impact disease.